Ran Nussbaum insider trades

Open-market stock purchases and sales by Ran Nussbaum, Unknown at LB Pharmaceuticals Inc, from SEC Form 4 filings since Jun 25, 2014.

Track record: 64% of 22 scored buys are up 5% or more since purchase, averaging +20%.

Recent trades

DateStockTradeValue
Jun 3, 2026LBRX LB Pharmaceuticals IncBought (not open market)—

Companies traded

  • LBRX LB Pharmaceuticals Inc: 1 buy, last Jun 3, 2026
  • KROS Keros Therapeutics, Inc: 8 buys, last Jun 4, 2025
  • URGN UroGen Pharma Ltd: other filings, last Oct 21, 2022
  • ELOX Eloxx Pharmaceuticals, Inc: 17 buys, last Jun 15, 2022
  • PRVL Prevail Therapeutics Inc: other filings, last Jan 22, 2021
  • ARQL Arqule Inc: 9 buys, last Jan 16, 2020
  • KITE Kite Pharma, Inc: 4 buys, 11 sales, last Oct 3, 2017

Get free alerts when Ran Nussbaum files a new trade →